Trial Profile
Effect of Sarpogrelate, a Serotonin Receptor Antagonist, on Progression of Coronary Artery Disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 May 2016
Price :
$35
*
At a glance
- Drugs Sarpogrelate (Primary) ; Aspirin
- Indications Coronary artery disease
- Focus Therapeutic Use
- Acronyms SAGE-CAD
- 02 May 2016 Status changed from recruiting to completed.
- 20 Nov 2015 New trial record